229 related articles for article (PubMed ID: 32656205)
41. Long noncoding RNA glypican 3 (GPC3) antisense transcript 1 promotes hepatocellular carcinoma progression via epigenetically activating GPC3.
Zhu XT; Yuan JH; Zhu TT; Li YY; Cheng XY
FEBS J; 2016 Oct; 283(20):3739-3754. PubMed ID: 27573079
[TBL] [Abstract][Full Text] [Related]
42. Overexpression of forkhead box C1 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma.
Xia L; Huang W; Tian D; Zhu H; Qi X; Chen Z; Zhang Y; Hu H; Fan D; Nie Y; Wu K
Hepatology; 2013 Feb; 57(2):610-24. PubMed ID: 22911555
[TBL] [Abstract][Full Text] [Related]
43. Long non-coding RNA NKILA inhibits migration and invasion of tongue squamous cell carcinoma cells via suppressing epithelial-mesenchymal transition.
Huang W; Cui X; Chen J; Feng Y; Song E; Li J; Liu Y
Oncotarget; 2016 Sep; 7(38):62520-62532. PubMed ID: 27613832
[TBL] [Abstract][Full Text] [Related]
44. Upregulated long non-coding RNA LOC90784 promotes cell proliferation and invasion and is associated with poor clinical features in HCC.
Xu JH; Chang WH; Fu HW; Shu WQ; Yuan T; Chen P
Biochem Biophys Res Commun; 2017 Aug; 490(3):920-926. PubMed ID: 28651931
[TBL] [Abstract][Full Text] [Related]
45. Sox12, a direct target of FoxQ1, promotes hepatocellular carcinoma metastasis through up-regulating Twist1 and FGFBP1.
Huang W; Chen Z; Shang X; Tian D; Wang D; Wu K; Fan D; Xia L
Hepatology; 2015 Jun; 61(6):1920-33. PubMed ID: 25704764
[TBL] [Abstract][Full Text] [Related]
46. Long Noncoding RNA lncARSR Promotes Doxorubicin Resistance in Hepatocellular Carcinoma via Modulating PTEN-PI3K/Akt Pathway.
Li Y; Ye Y; Feng B; Qi Y
J Cell Biochem; 2017 Dec; 118(12):4498-4507. PubMed ID: 28464252
[TBL] [Abstract][Full Text] [Related]
47. Ftx non coding RNA-derived miR-545 promotes cell proliferation by targeting RIG-I in hepatocellular carcinoma.
Liu Z; Dou C; Yao B; Xu M; Ding L; Wang Y; Jia Y; Li Q; Zhang H; Tu K; Song T; Liu Q
Oncotarget; 2016 May; 7(18):25350-65. PubMed ID: 26992218
[TBL] [Abstract][Full Text] [Related]
48. PBK overexpression promotes metastasis of hepatocellular carcinoma via activating ETV4-uPAR signaling pathway.
Yang QX; Zhong S; He L; Jia XJ; Tang H; Cheng ST; Ren JH; Yu HB; Zhou L; Zhou HZ; Ren F; Hu ZW; Gong R; Huang AL; Chen J
Cancer Lett; 2019 Jun; 452():90-102. PubMed ID: 30914208
[TBL] [Abstract][Full Text] [Related]
49. Increased long noncoding RNA LINC00511 is correlated with poor prognosis and contributes to cell proliferation and metastasis by modulating miR-424 in hepatocellular carcinoma.
Wang RP; Jiang J; Jiang T; Wang Y; Chen LX
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3291-3301. PubMed ID: 31081082
[TBL] [Abstract][Full Text] [Related]
50. Long non-coding RNA UBE2CP3 promotes tumor metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma.
Cao SW; Huang JL; Chen J; Hu YW; Hu XM; Ren TY; Zheng SH; Lin JD; Tang J; Zheng L; Wang Q
Oncotarget; 2017 Sep; 8(39):65370-65385. PubMed ID: 29029437
[TBL] [Abstract][Full Text] [Related]
51. HOXA-AS2 Promotes Proliferation and Induces Epithelial-Mesenchymal Transition via the miR-520c-3p/GPC3 Axis in Hepatocellular Carcinoma.
Zhang Y; Xu J; Zhang S; An J; Zhang J; Huang J; Jin Y
Cell Physiol Biochem; 2018; 50(6):2124-2138. PubMed ID: 30415263
[TBL] [Abstract][Full Text] [Related]
52. MCM6 promotes metastasis of hepatocellular carcinoma via MEK/ERK pathway and serves as a novel serum biomarker for early recurrence.
Liu M; Hu Q; Tu M; Wang X; Yang Z; Yang G; Luo R
J Exp Clin Cancer Res; 2018 Jan; 37(1):10. PubMed ID: 29357919
[TBL] [Abstract][Full Text] [Related]
53. Overexpression of long noncoding RNA
Zhu L; Huang F; Wan T; Xu H; Zhao Q
Onco Targets Ther; 2018; 11():5209-5217. PubMed ID: 30271163
[TBL] [Abstract][Full Text] [Related]
54. Long non-coding RNA LINC00673 promotes hepatocellular carcinoma progression and metastasis through negatively regulating miR-205.
Zhang LG; Zhou XK; Zhou RJ; Lv HZ; Li WP
Am J Cancer Res; 2017; 7(12):2536-2544. PubMed ID: 29312806
[TBL] [Abstract][Full Text] [Related]
55. Long non-coding RNA CARLo-5 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients.
Wang F; Xie C; Zhao W; Deng Z; Yang H; Fang Q
Clin Exp Med; 2017 Feb; 17(1):33-43. PubMed ID: 26433964
[TBL] [Abstract][Full Text] [Related]
56. Long non-coding RNA SBF2-AS1 promotes hepatocellular carcinoma progression through regulation of miR-140-5p-TGFBR1 pathway.
Li Y; Liu G; Li X; Dong H; Xiao W; Lu S
Biochem Biophys Res Commun; 2018 Sep; 503(4):2826-2832. PubMed ID: 30115383
[TBL] [Abstract][Full Text] [Related]
57. LncRNA KTN1-AS1 promotes tumor growth of hepatocellular carcinoma by targeting miR-23c/ERBB2IP axis.
Zhang L; Wang L; Wang Y; Chen T; Liu R; Yang W; Liu Q; Tu K
Biomed Pharmacother; 2019 Jan; 109():1140-1147. PubMed ID: 30551364
[TBL] [Abstract][Full Text] [Related]
58. Sorcin Predicts Poor Prognosis and Promotes Metastasis by Facilitating Epithelial-mesenchymal Transition in Hepatocellular Carcinoma.
Lei X; Liang Y; Chen J; Xiao S; Lei J; Li J; Duanmu J; Jiang Q; Liu D; Tang C; Li T
Sci Rep; 2017 Aug; 7(1):10049. PubMed ID: 28855589
[TBL] [Abstract][Full Text] [Related]
59. Long non-coding RNA CCAT2 is associated with poor prognosis in hepatocellular carcinoma and promotes tumor metastasis by regulating Snail2-mediated epithelial-mesenchymal transition.
Xu Y; Wang B; Zhang F; Wang A; Du X; Hu P; Zhu Y; Fang Z
Onco Targets Ther; 2017; 10():1191-1198. PubMed ID: 28280353
[TBL] [Abstract][Full Text] [Related]
60. The noncoding RNA HOXD-AS1 is a critical regulator of the metastasis and apoptosis phenotype in human hepatocellular carcinoma.
Lu S; Zhou J; Sun Y; Li N; Miao M; Jiao B; Chen H
Mol Cancer; 2017 Jul; 16(1):125. PubMed ID: 28724429
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
